Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Rheumatologist: June 2007

Reading Rheum

Daniel Hal Solomon, MD, MPH; Michael M. Ward, MD  |  June 1, 2007

Handpicked Reviews of Contemporary Literature

Science from our Sisters

Virginia Hughes  |  June 1, 2007

Recommended reading from A&R and AC&R

From Punch Cards to Patient Reporting

Gretchen Henkel  |  June 1, 2007

James F. Fries, MD, harnessed computers to address big questions

State-of-the-Art Care for Your Practice

Jane Jerrard  |  June 1, 2007

Clinical updates from the ACR Symposium

Coding Corner Question

Staff  |  June 1, 2007

June’s Coding Challenge

Coding Corner Answer

Staff  |  June 1, 2007

June’s coding answer

Rheumatology Audioconference Series Recordings

Staff  |  June 1, 2007

If you missed the 2007 ARHP audioconference series the first time around, here’s your opportunity to catch up. Recordings of the six 2007 audioconferences are available for purchase individually or as a set.

Free Lupus CD

Staff  |  June 1, 2007

The National Institute of Arthritis and Musculoskeletal and Skin Diseases is offering a free CD entitled “Lupus and Other Related Information for You and Your Patients.” The CD contains Lupus: A Patient Guide for Nurses and Other Health Professionals, 3rd Edition.

Changes and Choices for Clinicians

Staff  |  June 1, 2007

Clinician members will have more than enough sessions to keep them busy at the ACR Annual Scientific Meeting in Boston this November. The Annual Meeting Planning Committee (AMPC) continues to use attendee feedback and member input to create a meeting that offers vital content to every attendee.

Reimbursement Questions? Contact the RAC

Staff  |  June 1, 2007

The ACR Regional Advisory Council (RAC) met in March to discuss reimbursement issues affecting rheumatologists in various regions. The RAC was established to assist physicians with reimbursement concerns.

ACR Rheumatology Workforce Study Results Online

Staff  |  June 1, 2007

Results from the 2005–2006 ACR Rheumatology Workforce Study are now available online, and the state of the workforce—and its future—is clearer than ever. The purpose of the study was to better understand the factors affecting rheumatologist supply and demand.

Reactive Arthritis

Staff  |  June 1, 2007

Reactive arthritis is highlighted this month in our ongoing series on patient education materials.

AC&R to Publish Monthly in 2008

Staff  |  June 1, 2007

In order to meet the increasing demand for rheumatology-focused articles, AC&R will begin publishing 12 issues per year in January 2008. AC&R publishes both original research and review articles that promote excellence in the clinical practice of rheumatology. Covered topics include evidence-based practice studies; clinical problems; practice guidelines; healthcare economics; healthcare policy; educational, social, and public health issues; and future trends in rheumatology practice.

Contact Congress Today about Medicare Reimbursement

Staff  |  June 1, 2007

Changing the Medicare physician reimbursement formula so that it more accurately mirrors the cost of care is a top legislative concern for the ACR this year. The reimbursement scale is currently calculated using the sustainable growth rate (SGR), which is based on the gross domestic product and is irrelevant to medical care. The formula has steadily decreased physician reimbursement since its inception.

ARHP Progress Report

Karen L. Kerr, MSN, NP, CPNP, APRN-BC  |  June 1, 2007

The ARHP has made significant progress toward the goals identified in its long range plan for this year, and I would like to share some of these achievements with you.

ACR REF Niche Award Helps Define a Research Career

Staff  |  June 1, 2007

Joyce Hsu, MD, has always been interested in pediatric medicine and she found a perfect niche for herself in pediatric rheumatology. She completed a pediatric residency at the University of California, Los Angeles and worked as a general pediatrician for a year while considering rheumatology.

ACR Policy On Expert Witness Testimony

Staff  |  June 1, 2007

The ACR Board of Directors recently approved a policy and guidelines on expert witness testimony in medical malpractice litigation. Many ACR members have been called to testify in medical malpractice litigation—or will be called in the future—and the ACR recognized the need for medical expert testimony guidelines that serve the public interest by ensuring that testimony is readily available, objective, and unbiased.

Two Years of Helping Patients Obtain Prescriptions

Staff  |  June 1, 2007

April 5, 2007 marked the second anniversary of the Partnership for Prescription Assistance (PPA). Sponsored by America’s pharmaceutical research companies, the PPA helps lower income, uninsured, and underinsured patients obtain prescription medicines for free or at nominal cost.

Some Lupus Tests Yield False Results

Staff  |  June 1, 2007

The ACR’s Regional Advisory Council (RAC) has received several member reports of false results on antinuclear antibody (ANA) tests. The test screens for systemic lupus erythematosus, drug-induced lupus, and other diseases. Results are used to direct treatment, so accuracy is crucial.

UnitedHealth Group to Require MRI Accreditation

Staff  |  June 1, 2007

Starting March 1, 2008, UnitedHealth Group will require all freestanding facilities and physician offices that perform MRIs and certain other imaging studies to obtain accreditation. Physicians without accreditation will not be reimbursed for the technical or global codes. UnitedHealth Group is the umbrella organization for insurance companies such as United Healthcare, Ovations, and AmeriChoice.

Letters to the Editor

Staff  |  June 1, 2007

Feedback from Our Readers

Why I Still Like Being a Rheumatologist

Neal S. Birnbaum, MD  |  June 1, 2007

The rewards of practice outshine the lure of retirement

Medicare Quality Movement Reaches Clinicians

David Holzman  |  June 1, 2007

Physician Quality Reporting Initiative offers bonuses for clinicians and health professionals

NSAIDs: The Heart of the Controversy

Kurt Ullman  |  June 1, 2007

Rheumatologists on the AHA statement and how to balance NSAID risks and benefits

Build Up Bone

Nancy Lane, MD, and Wei Yao, MD  |  June 1, 2007

Current management of osteoporosis

Rheumatology Drug Updates: Uncertain Future for Romosozumab, Plus FDA Approves Tocilizumab for GCA

Michele B. Kaufman, PharmD, BCGP  |  July 20, 2017

Romosozumab’s Future Is Uncertain Romosozumab, which has the possible U.S. brand name Evenity, is awaiting approval from the FDA.1 The treatment is an investigational, injectable biologic for treating osteoporosis. It increases bone formation and bone density, reducing a patient’s risk of fractures. The manufacturer no longer expects the FDA to approve the drug this year…

Issue Archive

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences